🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to demonstrate the efficacy of ferric carboxymalto...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2017-07-03
Trial ID
NCT03591406
Treatments Being Tested
Hepatocellular cancer, one of the world's most deadly tumors, is associated...
Status
Completed
Location
Penn State Hershey Medical Center
Start Date
2008-06
Trial ID
NCT00706576
Treatments Being Tested
The purpose of this study is to assess the safety and potential efficacy of...
Status
Completed
Location
NewportNativeMD
Start Date
2022-04-14
Trial ID
NCT05228899
The aim of this study is to determine if fluorescence with or without indoc...
Status
Terminated
Location
UAB Callahan Eye
Start Date
2024-04-11
Trial ID
NCT06169735
Treatments Being Tested
This clinical study is a randomized, double-blind, double-dummy, parallel g...
Status
Suspended
Location
Sun City Clinical Research
Start Date
2022-12-14
Trial ID
NCT05324358
Treatments Being Tested
To compare the effects of perioperative intravenous Dexamethasone with a pl...
Status
Unknown
Location
Department of Orthopedics, Chiang Mai University
Start Date
2016-10
Trial ID
NCT02760459
Treatments Being Tested
ALT-100 is a monoclonal antibody developed by Aqualung Therapeutics Corp. a...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2022-07-05
Trial ID
NCT05426746
Treatments Being Tested
This Phase 1 study will be conducted to explore the dose regimen in humans ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-03
Trial ID
NCT04327310
Treatments Being Tested
The purpose of this Phase 1a study is to evaluate safety, tolerability, and...
Status
Completed
Location
Dr. Vince Clinical Research
Start Date
2024-02-07
Trial ID
NCT06316973
Treatments Being Tested
Aging is the primary risk factor for Alzheimer's disease (AD), which is a r...
Status
Completed
Location
Neurovascular Aging Laboratory
Start Date
2017-10-30
Trial ID
NCT03775382
Treatments Being Tested